These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy. Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861 [TBL] [Abstract][Full Text] [Related]
30. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease. Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366 [TBL] [Abstract][Full Text] [Related]
31. The diagnostic accuracy of the hummingbird and morning glory sign in patients with neurodegenerative parkinsonism. Mueller C; Hussl A; Krismer F; Heim B; Mahlknecht P; Nocker M; Scherfler C; Mair K; Esterhammer R; Schocke M; Wenning GK; Poewe W; Seppi K Parkinsonism Relat Disord; 2018 Sep; 54():90-94. PubMed ID: 29643007 [TBL] [Abstract][Full Text] [Related]
32. Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials. Höglinger GU; Schöpe J; Stamelou M; Kassubek J; Del Ser T; Boxer AL; Wagenpfeil S; Huppertz HJ; ; ; Mov Disord; 2017 Jun; 32(6):842-852. PubMed ID: 28436538 [TBL] [Abstract][Full Text] [Related]
33. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy. Tsai RM; Lobach I; Bang J; Whitwell JL; Senjem ML; Jack CR; Rosen H; Miller B; Boxer AL; Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501 [TBL] [Abstract][Full Text] [Related]
34. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic. Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297 [TBL] [Abstract][Full Text] [Related]
35. Eye movements and association with regional brain atrophy in clinical subtypes of progressive supranuclear palsy. Choi JH; Kim H; Shin JH; Lee JY; Kim HJ; Kim JM; Jeon B J Neurol; 2021 Mar; 268(3):967-977. PubMed ID: 32959131 [TBL] [Abstract][Full Text] [Related]
36. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy. Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700 [TBL] [Abstract][Full Text] [Related]
37. Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study. Hwang M; Yang H; Kim Y; Youn J; Park J; Huh YE; Kim HT; Cho JW Neurodegener Dis; 2017; 17(1):31-37. PubMed ID: 27614955 [TBL] [Abstract][Full Text] [Related]
38. Study of the rostral midbrain atrophy in progressive supranuclear palsy. Kato N; Arai K; Hattori T J Neurol Sci; 2003 Jun; 210(1-2):57-60. PubMed ID: 12736089 [TBL] [Abstract][Full Text] [Related]
40. Quantitative assessment of cerebral gray matter density change in progressive supranuclear palsy using voxel based morphometry analysis and cerebral MR T1-weighted FLAIR imaging. Wang G; Wang J; Zhan J; Nie B; Li P; Fan L; Zhu H; Feng T; Shan B J Neurol Sci; 2015 Dec; 359(1-2):367-72. PubMed ID: 26671144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]